Encapsulation of Biomolecules in Bacteriophage MS2 Viral Capsids
Total Page:16
File Type:pdf, Size:1020Kb
Encapsulation of Biomolecules in Bacteriophage MS2 Viral Capsids By Jeff Edward Glasgow A dissertation submitted in partial satisfaction of the requirements for the degree of Doctor of Philosophy in Chemistry in the Graduate Division of the University of California, Berkeley Committee in Charge: Professor Matthew Francis, Co-Chair Professor Danielle Tullman-Ercek, Co-Chair Professor Michelle Chang Professor John Dueber Spring 2014 Encapsulation of Biomolecules in Bacteriophage MS2 Viral Capsids Copyright ©2014 By: Jeff Edward Glasgow Abstract Encapsulation of Biomolecules in Bacteriophage MS2 Viral Capsids By Jeff Edward Glasgow Doctor of Philosophy in Chemistry University of California, Berkeley Professor Matthew Francis, Co-Chair Professor Danielle Tullman-Ercek, Co-Chair Nanometer-scale molecular assemblies have numerous applications in materials, catalysis, and medicine. Self-assembly has been used to create many structures, but approaches can match the extraordinary combination of stability, homogeneity, and chemical flexibility found in viral capsids. In particular, the bacteriophage MS2 capsid has provided a porous scaffold for several engineered nanomaterials for drug delivery, targeted cellular imaging, and photodynamic thera- py by chemical modification of the inner and outer surfaces of the shell. This work describes the development of new methods for reassembly of the capsid with concomitant encapsulation of large biomolecules. These methods were then used to encapsulate a variety of interesting cargoes, including RNA, DNA, protein-nucleic acid and protein-polymer conjugates, metal nanoparticles, and enzymes. To develop a stable, scalable method for encapsulation of biomolecules, the assembly of the capsid from its constituent subunits was analyzed in detail. It was found that combinations of negatively charged biomolecules and protein stabilizing agents could enhance reassembly, while electrostatic interactions of the biomolecules with the positively charged inner surface led to en- capsulation. To investigate the role protein shells play in encapsulated enzymatic processes, this method was then used to a model enzyme in a series of capsids with altered characteristics around the pores. The method was then used to develop a potential system for delivery of therapeutic pro- teins to the cytoplasm of cancer cells by encapsulating conjugates of these proteins to a negatively charged, membrane-lysing polymer. 1 Dedicated to my parents, Joe and Heidi Glasgow. i Table of Contents Abstract ..................................................................................................................... 1 Acknowledgments .................................................................................................... iv 1. Production and Applications of Engineered Viral Capsids ................................... 1 1.1 Abstract ......................................................................................................................................1 1.2 Introduction ................................................................................................................................2 1.3 Production: Recombinant vs. Infection ......................................................................................2 1.4 Production: Capsid Size and Assembly ......................................................................................3 1.5 Production: Surface Chemistry ..................................................................................................4 1.6 Applications: Drug Delivery ......................................................................................................4 1.7 Applications: Imaging Agents ....................................................................................................6 1.8 Applications: Templated Synthesis .............................................................................................7 1.9 Applications: Nanoreactors and Scaffolds .................................................................................9 1.10 Nonviral Protein Scaffolds .....................................................................................................10 1.11 Conclusions and Perspectives ................................................................................................11 1.12 References ..............................................................................................................................11 2. Osmolyte-Mediated Encapsulation of Proteins inside MS2 Viral Capsids......... 21 2.1 Abstract ....................................................................................................................................21 2.2 Introduction ..............................................................................................................................22 2.3 Reassembly of Wild-type MS2 ..................................................................................................23 2.4 Encapsulation of GFP ..............................................................................................................25 2.5 Encapsulation and Activity of Alkaline Phosphatase ..............................................................27 2.6 Summary ..................................................................................................................................29 2.7 Materials and Methods ............................................................................................................30 2.8 References ................................................................................................................................34 ii 3. The Influence of Electrostatics on Small Molecule Flux through a Protein Nano- reactor .................................................................................................................. 38 3.1 Abstract ....................................................................................................................................38 3.2 Introduction ..............................................................................................................................39 3.3 PhoA Kinetics in MS2 Pore Mutants .......................................................................................41 3.4 Modeling of Encapsulated Reactions .......................................................................................43 3.5 Conclusion ...............................................................................................................................45 3.6 Materials and Methods ............................................................................................................46 3.7 References ................................................................................................................................52 4. Toward Therapeutic Protein Delivery with MS2-Encapsulated Protein-polymer Conjugates ........................................................................................................... 55 4.1 Abstract ....................................................................................................................................55 4.2 Targeted Delivery of Therapeutic Proteins .............................................................................56 4.3 Polymer Conjugates in Cytosolic Protein Delivery .................................................................57 4.4 Conjugation of Negatively Charged Polymer Amphiphiles .....................................................57 4.5 Encapsulation of Protein-polymer Conjugates ........................................................................61 4.6 Therapeutic Protein Encapsulation .........................................................................................63 4.7 Materials and Methods ............................................................................................................66 4.8 References ................................................................................................................................73 iii Acknowledgments Berkeley has been such a great place for me to grow into a scientist, with so many people eager to lend help or support in developing this dissertation. As such there are innumerable people I should thank. Here are a few: Matt and Danielle—thank you for agreeing to take me on and start a new collaboration. You’ve both been so helpful with your ideas, enthusiasm, discussion, and support. The DTE lab—thank you for giving me such a fun, stimulating place to work. I have really en- joyed watching how the lab’s personality has grown and shifted since the first year. You have all made a huge impact on me as a scientist. Thanks to Chris for all the math help. Thanks to Anum, who has always been a great partner. The Francis lab—thank you for also taking me in and teaching me a little chemistry. The diversity of the both the research ideas and the people that have come through the lab has helped me see things from many different perspectives. Thanks to Stacy for lots of help and puppy pictures and Adel, Allie, Ioana, and Farkas for all their contributions. Other labs—there have been several other groups that have helped me over the years. Thanks to the M. Chang lab for basically being my third home in the department. Thanks to the Fréchet, Ber- tozzi, and Sarpong labs for being so generous with useful discussion and equipment. My Berkeley friends—both in and out of lab, I was lucky to have a great group of friends. I couldn’t